Advanz Pharma Ltd. has won a stay on the withdrawal of its primary biliary cholangitis (PBC) drug, Ocaliva (obeticholic acid), after the European Commission (EC) said on Sept. 3 that the conditional ...

Abbott Laboratories’ diabetes unit opened the month with a two-cannon salvo – a partnership with Beta Bionics Inc. that will integrate Abbott’s Freestyle Libre 3 Plus continuous glucose monitor with ...

The dark matter of long non-coding RNA (lncRNA) is shades brighter, after the signing of two major deals between biotech ...

Biopharma IPOs have faced tough conditions in recent years, but 2024 is showing signs of improvement in terms of value, while ...

Technological breakthroughs are changing the biopharmaceutical landscape and forcing regulators to think on their feet and ...

The U.S. FDA is accused of dragging its feet on making public the devices for which it granted market access under the de ...

Distinguishing between contract law and patent law, the U.S. Court of Appeals for the Third Circuit ruled against a Merck ...

Co. Ltd.’s SKG-1108, a novel one-time intravitreally delivered gene therapy, has been awarded U.S. orphan drug designation ...

Researchers from Bristol Myers Squibb Co. disclosed the structure and presented preclinical data for the dual inhibitor of ...

Acurastem Inc. has secured $4 million in grant funding from the California Institute for Regenerative Medicine (CIRM) to ...

Metagenomi Inc. has reported data from an ongoing preclinical study designed to provide evidence supporting the potential ...

Researchers from the National University of Singapore and affiliated organizations presented data from a study that ...